ViewRay registers for $69m IPO

ViewRay registers for an initial public offering worth up to $69 million for its MRIdian cancer detection and radiation treatment device. ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously." ViewRay Inc.News Well, Imaging, Initial Public Offering (IPO), Radiosurgery, Wall Street Beatread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news